Products for Research Use Only
RegisterLogin

Dihydrokavain

CAT: 0804-HY-N0920-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-N0920-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Dihydrokavain (7,8-Dihydrokawain) is a natural kavalactone compound. Dihydrokavain inhibits COX-1, COX-2, CYP2C9 (IC50 = 130.95 μM), CYP2C19 (IC50 = 10.05 μM) and CYP3A4 (IC50 = 78.59 μM) . Dihydrokavain reduces TNFα secretion. Dihydrokavain shows analgesic and anxiolytic effects[1][2][3][4][5].
CAS Number
587-63-3
Product Name Alternative
7,8-Dihydrokawain; 7,8-Dihydrokavain; Marindinin
UNSPSC
12352005
Hazard Statement
H302
Target
COX; Cytochrome P450
Type
Natural Products
Related Pathways
Immunology/Inflammation; Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/Dihydrokavain.html
Purity
99.94
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C1C=C(OC)C[C@H](CCC2=CC=CC=C2)O1
Molecular Formula
C14H16O3
Molecular Weight
232.28
Precautions
H302
References & Citations
[1]Feltenstein MW, et al. Anxiolytic properties of Piper methysticum extract samples and fractions in the chick social-separation-stress procedure. Phytother Res. 2003 Mar;17 (3) :210-6.|[2]Rowe A, et al. Kavalactone pharmacophores for major cellular drug targets. Mini Rev Med Chem. 2011 Jan;11 (1) :79-83.|[3]Xia Q, et al. Phototoxicity of kava - formation of reactive oxygen species leading to lipid peroxidation and DNA damage. Am J Chin Med. 2012;40 (6) :1271-88.|[4]Bian T, et al. Kava as a Clinical Nutrient: Promises and Challenges. Nutrients. 2020 Oct 5;12 (10) :3044.|[5]Anke J, et al. Pharmacokinetic and pharmacodynamic drug interactions with Kava (Piper methysticum Forst. f.) . J Ethnopharmacol. 2004 Aug;93 (2-3) :153-60.|[6]Jamieson DD, et al. The antinociceptive actions of kava components in mice. Clin Exp Pharmacol Physiol. 1990 Jul;17 (7) :495-507.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
COX-1; COX-2; CYP2C19; CYP2C9; CYP3A4

Alternative Products

CatalogName
M18856-01Dihydrokavain
TRC-D450620-5MG(+)-(S)-Dihydrokavain
371368Dihydrokavain discontinued
465604-01(+) -S-Dihydrokavain

Popular Products